MedTrace Logo

Association Between the Use of Pulmonary Artery Catheter and Clinical Outcomes After Liver Transplantation

NCT05457114 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1970

Last updated 2022-07-15

No results posted yet for this study

Summary

The investigators attempted to evaluate whether the use of PAC is associated with better clinical outcomes after liver transplantation compared with the case without PAC.

Conditions

Interventions

DEVICE

Pulmonary artery catheter (Edward Lifesciences, Irvine, California, USA)

PAC was inserted and connected to a continuous cardiac output monitor (Vigilance I from 2006 to 2012; Vigilance II from 2012 to 2022, Edward Lifesciences, Irvine, USA)

DEVICE

FloTrac Vigileo system (EV1000 clinical platform, Edward Lifesciences, Irvine, California, USA)

Without PAC, monitoring with FloTrac Vigileo system (EV1000 clinical platform, Edward Lifesciences, Irvine, California, USA) was performed for continuous cardiac output monitoring.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Won Ho Kim, MD, PhD · Department of Anaesthesiology and Pain Medicine, Seoul National University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05457114 on ClinicalTrials.gov